chickpea_recomp
Member
The anti-inflammatory mechanism of GLP-1 affecting multiple autoimmune conditions simultaneously is the clinical picture that makes the most sense - the pathway modulation is not condition-specific and can affect several inflammatory processes in parallel. Multi-condition improvement is one of the better arguments for treating the metabolic root rather than each condition separately.